欧美少妇一区二区三区在线观看,综合日韩欧美在线,亚洲精品欧美另类,亚洲第一成人一区二区,午夜精品欧美视频,欧美综合_区二区三区,亚洲免费成人在线观看,亚洲麻豆精品久久,91精品国产综合久久久久久久色,女主播午夜福利视频,亚洲熟女少妇一区二区视频,九九九九九九精品免费,亚洲蜜臀av一区二区三区,国内免费精品一区二区三区,亚洲毛片免费电影,国产精品久久久久性,亚洲一区二区三区国产区,日韩欧美人妻区一区二区,午夜一区二区三区黄色,亚洲欧美综合人成野草,激情欧美日韩综合,亚洲精品十八禁一区二区三区,中文字幕欧美一区

         2023年賽國生物取得北京博奧森生物一級代理權。

        成立于2001年，北京博奧森生物技術有限公司有2000萬元注冊資本，是集免疫學科研試劑研發、生產、售為體的國家高新技術企業。在公司近1300平米的研發中心樓內，擁有SPF級實驗動物房、GMP級單克隆抗體制備平臺，同時購置了CSBio多肽合成儀、Akta全自動液相色譜系統、BD流式細胞儀、Leica冷凍切片機等多種生產、檢測儀器。公司還擁有一批技術精湛、經驗豐富的科研發團隊，在免疫和分子生物學等領域擁有多項自主知識產權。

        自成立之初，公司始終秉持“自主研發、原始創新，為全球生命科學研究提供優質服務”的經營理念。提供全面的科研抗體、試劑，診斷抗體原料，以及CRO服務。公司現擁有近兩萬種抗體產品，涵蓋人蛋白靶點13000多個。特色產品有特異磷酸化抗體及專利授權AF熒光標記抗體等。此外，公司還提供完善的單/多克隆抗體制備、標記、重組蛋白、多肽合成及各項免疫學檢測技術服務等。公司恪守ISO9001:2008國際質量管理體系認證要求，致力于打造“Bioss”精品抗體品牌。 2010年博奧森（波士頓）在美國設立了面向全球抗體市場的商務拓展及國際市場營總部，不斷擴展全球售體系，主打Bioss國際品牌，向全球科研工作者提供高質量的科研抗體產品。迄今為止，Bioss產品已遍布全球多個國家和地區，并已成為數家國際知名抗體公司的OEM合作伙伴。Bioss抗體產品已出現在數千篇高質量SCI文章中，獲得了全世界眾多生命科學領域科研人員的認可。

       百舸爭流，只爭朝夕。近二十年的探索和拼搏，為Bioss品牌在免疫學試劑領域奠定了堅實的基礎。我們將在未來勇于拓，自主創新，為生命科學研究提供更加優質的產品和服務，回報全球用戶的信任，為生命科學進步盡綿薄之力。

       In 2023, Saiguo Biotech obtained the first-class agent right of Beijing Bioss.

      Established in 2001, Beijing Biossen Biotechnology Co., Ltd. has a registered capital of 20 million RMB and is a national high-tech enterprise integrating R&D, production and sales of immunology research reagents. In the company's R&D center building of nearly 1300 square meters, we have SPF-grade laboratory animal room, GMP-grade monoclonal antibody preparation platform, and we have also purchased a variety of production and testing instruments such as CSBio peptide synthesizer, Akta automatic liquid chromatography system, BD flow cytometer and Leica frozen section machine. The company also has a group of skilled and experienced research and development team, and owns a number of independent intellectual property rights in the fields of immunology and molecular biology.

     Since its inception, the company has been upholding the business philosophy of "independent research and development, original innovation, and providing quality services for global life science research". We provide a comprehensive range of research antibodies, reagents, diagnostic antibody materials and CRO services. The company now has nearly 20,000 antibody products, covering more than 13,000 human protein targets. Featured products include specific phosphorylated antibodies and patent-licensed AF fluorescence labeled antibodies. In addition, the company also provides complete mono/polyclonal antibody preparation, labeling, recombinant protein, peptide synthesis and various immunological assay technology services. The company adheres to the requirements of ISO9001:2008 international quality management system certification, and is committed to building the "Bioss" brand of high-quality antibodies. In 2010, Bioss (Boston) set up its business development and international marketing headquarters in the United States for the global antibody market, expanding its global sales system, and providing high-quality research antibody products to researchers worldwide under the Bioss international brand. Bioss antibody products have been featured in thousands of high-quality SCI articles and are recognized by researchers in the life science field worldwide.

       A hundred boats are competing for each other, and it is only a matter of time. Nearly two decades of exploration and hard work have laid a solid foundation for the Bioss brand in the field of immunology reagents. In the future, we will be brave to develop and innovate independently to provide more high-quality products and services for life science research, to repay the trust of global users, and to do our best for the progress of life science.

【2022/12/28 15:16:10】